$OPY

Oppenheimer Holdings Inc. Reports Second Quarter 2026 Earnings

Oppenheimer Holdings (NYSE: OPY) reported Q2 2026 net income of $27.4M, or $2.55 basic EPS, up from $21.7M, or $2.06 EPS, a year earlier. Revenue rose 21.9% to $454.9M. Adjusted net income was $45.7M, or $4.27 EPS, after excluding a $24.9M pre-tax stock-price-linked compensation expense.

Original reporting
Published Jul 31, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 12:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oppenheimer Holdings Inc. Reports Second Quarter 2026 Earnings — source image
Decision brief

The 30-second read

$OPYNeutralMed
01

Why it matters

Traders will likely focus on the gap between reported and adjusted earnings, the magnitude of stock appreciation rights expense, and segment revenue drivers (investment banking, equities options commissions, and AUM-driven advisory fees).

02

Market read

Fresh earnings numbers plus a quantified explanation for why reported EPS lagged adjusted EPS should drive immediate repricing and positioning.

03

What to watch

Sweep income declined due to lower short-term interest rates, which could cap future earnings even if AUM remains elevated.

Relevance 9/10Novelty 8/10Timing: reported Q2 2026 earnings today (July 31, 2026)

Background

Oppenheimer Holdings is a wealth management and capital markets firm; this release details both reported and non-GAAP adjusted results plus segment drivers.

Company-level read

Ticker impact

$OPYNeutralMedium confidence
Context

Oppenheimer reported Q2 2026 net income of $27.4M and revenue of $454.9M, with results pressured by a $24.9M stock-price-linked compensation expense.

Expected impact

Likely near-term volatility as traders reconcile adjusted strength versus reported EPS pressure from stock-linked compensation.

Evidence & confidence

The article provides concrete earnings and the specific pre-tax expense mechanism ($24.9M) plus adjusted net income ($45.7M), which can drive different interpretations for valuation and compensation cost trajectory.

Market effects

Signals that wealth management and capital markets revenues remain sensitive to equity market levels and volatility, with compensation costs moving with stock prices.

Primarily US capital markets and wealth management sentiment, tied to domestic equity performance.

Limited direct global spillover, though it references AI and Middle East de-escalation sentiment affecting equity conditions.

Counterpoint

Adjusted earnings strength may overstate sustainable profitability if stock-price-linked compensation and legal accruals are recurring or structurally rising.

Key entities

  • Oppenheimer Holdings Inc.

    Reported Q2 2026 earnings and segment performance, including a $24.9M pre-tax compensation expense tied to OPY’s stock price.

  • Wealth Management

    Q2 2026 revenue $272.7M, with AUM reaching a record $59.4B and sweep income down due to lower short-term rates.

  • Capital Markets

    Q2 2026 revenue $179.2M, with investment banking advisory fees up 158.5% and equities sales and trading up 37.8%.

Related articles

$OPYHigh

Why is Oppenheimer Holdings stock gaining over 2% today?

Oppenheimer Holdings stock rose 2.7% in pre-market trading to $123.25, surpassing its 52-week high, as the company distributed a $0.20 per share dividend. This follows strong Q2 2026 earnings, with revenue up 21.9% YoY to $454.9M and adjusted EPS at $4.27. Client assets under management reached a record $59.4B. The stock's technical breakout and positive fundamentals drove the gain, independent of broader market trends.

$ISRGMed

Oppenheimer Just Upgraded Intuitive Surgical Stock. Here's Why.

Oppenheimer upgraded Intuitive Surgical (ISRG) from “Perform” to “Outperform” and set a $500 price target, implying about 24.6% upside, citing robotic surgery growth and AI plans. The article notes Q2 revenue of $2.89B (vs $2.82B expected), EPS $2.80, da Vinci and Ion procedure growth, and ISRG guidance for da Vinci growth of 13.5% to 15.5%.

$OPYMedAI 8/10

OPPENHEIMER HOLDINGS INC (OPY): Results of Operations and Financial Condition

OPPENHEIMER HOLDINGS INC (OPY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Oppenheimer Holdings Inc. Reports Second Quarter 2026 Earnings New York, July 31, 2026 – Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $27.4 million or $2.55 basic earnings per share for the second quarter of 2026, compa